BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 25688915)

  • 21. Acoustic vowel analysis and speech intelligibility in young adult Hebrew speakers: Developmental dysarthria versus typical development.
    Carl M; Icht M
    Int J Lang Commun Disord; 2021 Mar; 56(2):283-298. PubMed ID: 33522087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acoustic and Perceptual Consequences of Speech Cues for Mandarin Speakers With Parkinson's Disease.
    Hsu SC; McAuliffe MJ; Lin P; Wu RM; Levy ES
    Am J Speech Lang Pathol; 2019 May; 28(2):521-535. PubMed ID: 31136238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal and spectral aspects of coarticulation in ataxic dysarthria: an acoustic analysis.
    Hertrich I; Ackermann H
    J Speech Lang Hear Res; 1999 Apr; 42(2):367-81. PubMed ID: 10229453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Stress and Speech Rate on Vowel Coarticulation in Catalan Vowel-Consonant-Vowel Sequences.
    Recasens D
    J Speech Lang Hear Res; 2015 Oct; 58(5):1407-24. PubMed ID: 26106868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vowel articulation in Parkinson's disease.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Jul; 25(4):467-72. PubMed ID: 20434876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.
    Weismer G; Jeng JY; Laures JS; Kent RD; Kent JF
    Folia Phoniatr Logop; 2001; 53(1):1-18. PubMed ID: 11125256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
    Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
    Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease.
    Hartelius L; Svantesson P; Hedlund A; Holmberg B; Revesz D; Thorlin T
    Folia Phoniatr Logop; 2010; 62(3):104-9. PubMed ID: 20424465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perception of coarticulatory information in normal speech and dysarthria.
    Tjaden K; Sussman J
    J Speech Lang Hear Res; 2006 Aug; 49(4):888-902. PubMed ID: 16908883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study.
    El Sharkawi A; Ramig L; Logemann JA; Pauloski BR; Rademaker AW; Smith CH; Pawlas A; Baum S; Werner C
    J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):31-6. PubMed ID: 11784821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intrinsic and co-intrinsic vowel characteristics in cerebellar and parkinsonian dysarthrias].
    Baudelle E; Vaissière J; Renard JL; Roubeau B; Chevrie-Müller C
    Folia Phoniatr Logop; 2003; 55(3):137-46. PubMed ID: 12771465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The locus equation as an index of coarticulation in syllables produced by speakers with profound hearing loss.
    McCaffrey Morrison H
    Clin Linguist Phon; 2008 Sep; 22(9):726-40. PubMed ID: 18608246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acoustic analysis of vowels following glossectomy.
    Whitehill TL; Ciocca V; Chan JC; Samman N
    Clin Linguist Phon; 2006; 20(2-3):135-40. PubMed ID: 16428229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of changes in hearing status in cochlear implant users on the acoustic vowel space and CV coarticulation.
    Lane H; Matthies M; Perkell J; Vick J; Zandipour M
    J Speech Lang Hear Res; 2001 Jun; 44(3):552-63. PubMed ID: 11407560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.
    Miles A; Jardine M; Johnston F; de Lisle M; Friary P; Allen J
    J Neurol Sci; 2017 Dec; 383():180-187. PubMed ID: 29246611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vowel contrast and speech intelligibility in dysarthria.
    Kim H; Hasegawa-Johnson M; Perlman A
    Folia Phoniatr Logop; 2011; 63(4):187-94. PubMed ID: 20938200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of Interactive Context on Acoustic Characteristics of Speech in People With Dysarthria: A Preliminary Study.
    Krajewski E; Lee J; Viswanathan N; Olmstead A; Simmons Z
    Am J Speech Lang Pathol; 2024 Jul; 33(4):1952-1964. PubMed ID: 38809826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus.
    Spielman J; Mahler L; Halpern A; Gilley P; Klepitskaya O; Ramig L
    J Commun Disord; 2011; 44(6):688-700. PubMed ID: 21724193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders.
    Fox CM; Ramig LO; Ciucci MR; Sapir S; McFarland DH; Farley BG
    Semin Speech Lang; 2006 Nov; 27(4):283-99. PubMed ID: 17117354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
    Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
    Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.